Desano Holdings Overview
- Year Founded
-
1996
- Status
-
Private
- Employees
-
115
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
7
- Investments
-
3
Desano Holdings General Information
Description
Manufacturer and developer of pharmaceutical products, preparations, and intermediates designed to meet growing demand of global treatment of HIV and malaria. The company's products include anti-viral and anti-malarial drugs as well as finished antibiotics, anti-retrovirals and cardiovascular drugs, enabling doctors across the world to treat debilitating diseases.
Contact Information
Website
www.desano.comCorporate Office
- No.1479 Zhangheng Road
- Zhangjiang High-tech Park
- Shanghai, 201203
- China
Corporate Office
- No.1479 Zhangheng Road
- Zhangjiang High-tech Park
- Shanghai, 201203
- China
Desano Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Desano Holdings Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Desano Holdings Patents
Desano Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4083039-A4 | Method for preparing isavuconazonium sulfate | Pending | 25-Dec-2019 | ||
| AU-2020414895-B2 | Method for preparing isavuconazonium sulfate | Active | 25-Dec-2019 | ||
| AU-2020414895-A1 | Method for preparing isavuconazonium sulfate | Active | 25-Dec-2019 | ||
| EP-4083039-A1 | Method for preparing isavuconazonium sulfate | Pending | 25-Dec-2019 | ||
| US-20230075632-A1 | Method for preparing isavuconazonium sulfate | Pending | 25-Dec-2019 | C07D417/14 |
Desano Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Desano Holdings Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Desano Holdings Investments (3)
Desano Holdings’s most recent deal was a Later Stage VC with Kangfude Pharmaceutical for . The deal was made on 24-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Kangfude Pharmaceutical | 24-Jul-2024 | Later Stage VC | Drug Discovery | ||
| Genuine Biotech | 12-Apr-2022 | Later Stage VC | Pharmaceuticals | ||
| Norchem Pharmaceutical | 27-Jan-2022 | Secondary Transaction - Private | Drug Discovery |
Desano Holdings FAQs
-
When was Desano Holdings founded?
Desano Holdings was founded in 1996.
-
Where is Desano Holdings headquartered?
Desano Holdings is headquartered in Shanghai, China.
-
What is the size of Desano Holdings?
Desano Holdings has 115 total employees.
-
What industry is Desano Holdings in?
Desano Holdings’s primary industry is Pharmaceuticals.
-
Is Desano Holdings a private or public company?
Desano Holdings is a Private company.
-
What is Desano Holdings’s current revenue?
The current revenue for Desano Holdings is .
-
Who are Desano Holdings’s investors?
CCBT Private Equity, CCIG Capital, CICC Jia Cheng Investment Management Company, Healthib Capital, and Xiamen Torch Group Venture Capital are 5 of 21 investors who have invested in Desano Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
